AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
172.48
+2.84 (1.67%)
At close: Jul 28, 2026, 4:00 PM EDT
171.00
-1.48 (-0.86%)
After-hours: Jul 28, 2026, 7:54 PM EDT
AstraZeneca Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
| 267,012 | 294,105 | 305,877 | 272,184 | 231,830 | 216,720 | 228,500 | 201,571 | 241,567 | 242,260 | 212,318 | 208,419 | 209,315 | 223,026 | 217,227 | 211,114 | 165,952 | 199,744 | 208,603 | 179,498 | |
Market Cap Growth (YoY) | 18.54% | 35.71% | 33.86% | 35.03% | -4.03% | -10.54% | 7.62% | -3.29% | 15.41% | 8.62% | -2.26% | -1.28% | 26.13% | 11.66% | 4.13% | 17.61% | -11.90% | 25.41% | 57.57% | 35.39% |
Enterprise Value | 294,544 | 321,451 | 332,171 | 296,117 | 256,363 | 242,542 | 254,843 | 226,297 | 268,285 | 268,803 | 238,904 | 231,102 | 232,800 | 247,076 | 242,290 | 233,962 | 190,373 | 224,404 | 233,898 | 203,900 |
Last Close Price | 172.48 | 189.62 | 197.22 | 175.50 | 149.50 | 139.76 | 147.36 | 130.00 | 155.82 | 156.27 | 136.96 | 134.45 | 135.05 | 143.90 | 140.16 | 136.22 | 107.10 | 128.91 | 134.63 | 115.85 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.56 | 28.34 | 29.66 | 26.83 | 24.83 | 26.32 | 29.59 | 28.89 | 37.37 | 37.75 | 33.65 | 35.29 | 35.63 | 36.34 | 46.41 | 64.56 | 81.76 | - | - | 1448.13 |
PS Ratio | 4.35 | 4.79 | 5.06 | 4.63 | 3.99 | 3.84 | 4.16 | 3.73 | 4.72 | 4.93 | 4.46 | 4.55 | 4.65 | 5.01 | 4.96 | 4.76 | 3.68 | 4.54 | 5.03 | 4.80 |
PB Ratio | 5.30 | 5.85 | 6.46 | 5.59 | 5.05 | 4.85 | 5.57 | 4.94 | 5.93 | 6.13 | 5.67 | 5.32 | 5.63 | 5.96 | 6.07 | 5.70 | 4.72 | 5.56 | 5.74 | 4.57 |
P/FCF Ratio | 25.03 | 27.57 | 27.09 | 23.14 | 18.31 | 19.39 | 20.49 | 20.28 | 25.18 | 25.71 | 26.00 | 23.20 | 22.86 | 24.66 | 25.29 | 24.22 | 21.31 | 30.44 | 33.80 | 36.84 |
P/OCF Ratio | 19.49 | 21.47 | 21.51 | 18.67 | 15.31 | 16.19 | 17.46 | 16.99 | 21.31 | 21.89 | 21.89 | 20.15 | 20.20 | 21.91 | 22.37 | 21.52 | 18.80 | 26.22 | 28.73 | 30.10 |
EV Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.80 | 5.24 | 5.50 | 5.04 | 4.41 | 4.29 | 4.64 | 4.19 | 5.24 | 5.47 | 5.02 | 5.04 | 5.17 | 5.55 | 5.53 | 5.28 | 4.22 | 5.10 | 5.64 | 5.45 |
EV/EBITDA Ratio | 14.49 | 15.81 | 16.50 | 15.20 | 13.24 | 13.36 | 14.75 | 13.56 | 18.03 | 18.94 | 17.19 | 17.02 | 17.13 | 19.10 | 21.83 | 25.33 | 22.23 | 31.62 | 33.03 | 26.88 |
EV/EBIT Ratio | 21.08 | 23.01 | 23.20 | 21.55 | 20.03 | 21.42 | 24.13 | 22.62 | 29.16 | 29.71 | 27.28 | 28.21 | 28.91 | 33.64 | 44.65 | 62.27 | 80.33 | - | 5997.38 | 193.09 |
EV/FCF Ratio | 27.61 | 30.13 | 29.41 | 25.17 | 20.25 | 21.70 | 22.85 | 22.77 | 27.97 | 28.53 | 29.25 | 25.72 | 25.43 | 27.32 | 28.21 | 26.84 | 24.45 | 34.20 | 37.90 | 41.85 |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.52 | 0.52 | 0.55 | 0.54 | 0.57 | 0.58 | 0.68 | 0.68 | 0.74 | 0.71 | 0.75 | 0.59 | 0.62 | 0.67 | 0.77 | 0.64 | 0.67 | 0.76 | 0.79 | 0.74 |
Debt / EBITDA Ratio | 1.59 | 6.33 | 6.04 | 6.60 | 6.36 | 6.71 | 6.38 | 6.93 | 8.05 | 8.33 | 7.91 | 11.18 | 8.83 | 8.00 | 7.78 | 11.36 | 11.36 | 15.57 | 14.22 | 16.20 |
Debt / FCF Ratio | 3.02 | 15.34 | 12.06 | 22.68 | 7.34 | 12.04 | 9.64 | 13.78 | 10.64 | 12.41 | 16.70 | 15.43 | 10.22 | 20.61 | 10.92 | 14.43 | 10.92 | 29.68 | 10.32 | 28.11 |
Net Debt / Equity Ratio | 0.54 | 0.54 | 0.55 | 0.49 | 0.53 | 0.57 | 0.64 | 0.60 | 0.65 | 0.67 | 0.71 | 0.58 | 0.63 | 0.64 | 0.70 | 0.62 | 0.70 | 0.69 | 0.70 | 0.62 |
Net Debt / EBITDA Ratio | 1.34 | 5.36 | 4.68 | 5.32 | 4.76 | 5.25 | 5.30 | 5.64 | 6.79 | 6.57 | 6.07 | 8.85 | 7.25 | 6.44 | 6.18 | 8.87 | 9.46 | 13.00 | 11.56 | 12.83 |
Net Debt / FCF Ratio | 2.56 | 12.97 | 9.33 | 18.29 | 5.50 | 9.44 | 7.99 | 11.21 | 8.98 | 9.79 | 12.82 | 12.22 | 8.39 | 16.59 | 8.68 | 11.27 | 9.10 | 24.77 | 8.39 | 22.27 |
Asset Turnover | 0.13 | 0.13 | 0.14 | 0.14 | 0.14 | 0.13 | 0.13 | 0.15 | 0.13 | 0.13 | 0.13 | 0.12 | 0.12 | 0.12 | 0.11 | 0.11 | 0.11 | 0.13 | 0.14 | 0.14 |
Inventory Turnover | 1.65 | 0.38 | 0.43 | 0.53 | 0.46 | 0.41 | 0.40 | 0.51 | 0.56 | 0.41 | 0.43 | 0.46 | 0.40 | 0.35 | 0.30 | 0.42 | 0.38 | 0.55 | 0.59 | 0.71 |
Quick Ratio | 0.61 | 0.61 | 0.67 | 0.68 | 0.66 | 0.63 | 0.64 | 0.67 | 0.65 | 0.63 | 0.66 | 0.59 | 0.57 | 0.64 | 0.67 | 0.64 | 0.57 | 0.63 | 0.64 | 0.71 |
Current Ratio | 0.89 | 0.89 | 0.91 | 0.94 | 0.88 | 0.86 | 0.90 | 0.93 | 0.93 | 0.89 | 0.89 | 0.82 | 0.79 | 0.87 | 0.90 | 0.86 | 0.81 | 0.96 | 1.00 | 1.16 |
Return on Equity (ROE) | 5.27% | 5.27% | 6.96% | 5.20% | 5.84% | 5.80% | 7.43% | 3.75% | 3.67% | 5.01% | 5.95% | 2.52% | 3.81% | 4.96% | 5.00% | 2.36% | 4.37% | 1.39% | 1.53% | -1.26% |
Return on Assets (ROA) | 2.48% | 2.48% | 3.03% | 2.42% | 2.55% | 2.53% | 3.03% | 1.79% | 1.64% | 2.20% | 2.44% | 1.34% | 1.71% | 2.22% | 2.06% | 1.26% | 2.20% | 0.92% | 0.75% | -0.18% |
Return on Invested Capital (ROIC) | 3.75% | 3.75% | 4.57% | 3.69% | 3.97% | 3.98% | 4.75% | 2.76% | 2.47% | 3.40% | 3.85% | 2.15% | 2.67% | 3.50% | 3.37% | 2.12% | 3.69% | 1.29% | 0.98% | -0.25% |
Return on Capital Employed (ROCE) | 3.88% | 3.88% | 5.36% | 3.73% | 4.50% | 4.54% | 4.88% | 2.77% | 2.88% | 3.76% | 4.29% | 1.75% | 2.86% | 3.39% | 3.41% | 1.43% | 1.63% | 0.85% | 1.45% | -0.45% |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.91% | 3.53% | 3.37% | 3.73% | 4.03% | 3.80% | 3.38% | 3.46% | 2.68% | 2.65% | 2.97% | 2.83% | 2.81% | 2.75% | 2.15% | 1.55% | 1.22% | - | - | 0.07% |
FCF Yield | 4.00% | 3.63% | 3.69% | 4.32% | 5.46% | 5.16% | 4.88% | 4.93% | 3.97% | 3.89% | 3.85% | 4.31% | 4.37% | 4.05% | 3.95% | 4.13% | 4.69% | 3.29% | 2.96% | 2.71% |
Dividend Yield | 1.87% | 0.00% | 1.08% | 0.00% | 0.69% | 0.00% | 1.47% | 0.00% | 0.65% | 0.01% | 1.43% | 0.00% | 0.67% | 0.01% | 1.40% | 0.00% | 0.84% | 0.00% | 1.43% | 0.00% |
Payout Ratio | 48.35% | 0.04% | 106.72% | 0.13% | 63.60% | 0.41% | 114.78% | 0.20% | 110.29% | 0.88% | 139.19% | 0.21% | 102.62% | 1.21% | 169.00% | 0.00% | 84.94% | 0.00% | 769.69% | 0.00% |
Buyback Yield / Dilution | 0.03% | -0.06% | 0.00% | -0.06% | 0.06% | 0.06% | -0.06% | -0.06% | -0.13% | 0.00% | 0.00% | -0.13% | -0.06% | 0.00% | 0.06% | -0.78% | -4.21% | -18.36% | -18.35% | -17.82% |
Total Shareholder Return | 1.91% | -0.06% | 1.08% | -0.06% | 0.76% | 0.07% | 1.40% | -0.06% | 0.52% | 0.01% | 1.43% | -0.13% | 0.61% | 0.01% | 1.47% | -0.78% | -3.37% | -18.36% | -16.92% | -17.82% |